ALSERES PHARMACEUTICALS INC /DE Research and Development in Process
ALSERES PHARMACEUTICALS INC /DE reported Research and Development in Process of $12.15 million for the 254-month period ending 2013-12-31, per its 10-K filed 2014-04-10.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2014-04-10
- 2013-12-31: .
- 2013-09-30: .
- 2013-06-30: .
- 2013-03-31: .
| Period end | Research and Development in Process 224 month | Research and Development in Process 227 month | Research and Development in Process 230 month | Research and Development in Process 233 month | Research and Development in Process 236 month | Research and Development in Process 239 month | Research and Development in Process 242 month | Research and Development in Process 245 month | Research and Development in Process 248 month | Research and Development in Process 251 month | Research and Development in Process 254 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $12.15M 10-K · filed 2014-04-10 | ||||||||||
| 2013-09-30 | $12.15M 10-Q · filed 2013-11-14 | ||||||||||
| 2013-06-30 | $12.15M 10-Q · filed 2013-08-09 | ||||||||||
| 2013-03-31 | $12.15M 10-Q · filed 2013-05-17 | ||||||||||
| 2012-12-31 | $12.15M 10-K · filed 2013-04-01 | ||||||||||
| 2012-09-30 | $12.15M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | $12.15M 10-Q · filed 2012-08-13 | ||||||||||
| 2012-03-31 | $12.15M 10-Q · filed 2012-05-11 | ||||||||||
| 2011-12-31 | $12.15M 10-K · filed 2012-03-29 | ||||||||||
| 2011-09-30 | $12.15M 10-Q · filed 2011-11-10 | ||||||||||
| 2011-06-30 | $12.15M 10-Q · filed 2011-08-11 |